Personal empowerment program: Addressing health concerns in people with schizophrenia

Journal of Psychosocial Nursing and Mental Health Services

Volumn 44, Issue 8, 2006, Pages 20-28

  Klam, Joan ^a   McLay, Myrna ^a   Grabke, Diane ^a  

^a FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748279619     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20060801-04     Document Type: Review

References (16)

1. th ed.). Washington, DC: Author.
2. Baptists, T., Zarate, J., Joober, R., Colasante, C., Beaulieu, S., Paez, X., et al. (2004). Drug induced weight gain, and impediment to successful pharmacotherapy: Focus on antipsychotics. Current Drug Targets, 5, 279-299.
3. Brown, S., Birtwistle, R.L., & Thompson, C. (1999). The unhealthy lifestyle of people with schizophrenia. Psychological Medicine, 29, 697-701.
4. Finfgeld, D.L. (2004). Empowerment of individuals with enduring mental health problems: Results from concept analyses and qualitative investigations. Advances in Nursing Science, 27(1), 44-52.
5. Holt, R.I.G., Pevelert, R.C., & Byrne, C.D. (2004). Schizophrenia, the metabolic syndrome and diabetes. Diabetic Medicine, 21, 515-523.
6. Iqbal, N., Oldan, R.L., Baird, G., Schwartz, B., Bloy, L., Bhagoji, B., et al. (2000, May). Diabetes mellitus induced by atypical antipsychotics. Paper presented at the annual meeting of the American Psychiatric Association, Chicago, IL.
7. Keck, P.E., & Kane, J.M. (2003). Partial agonism; Effectiveness in acute mania and refractory schizophrenia. Irvine, CA: Continuing Medical Education, U.S. Psychiatric and Mental Health Congress.
8. Kermode-Scott, B. (2002, November 26). Schizophrenics need more cardio care than others. Medical Post, 38, 24.
9. Masand, P.S. (2000). Weight gain associated with psychotropic drugs. Expert Opinion on Pharmacotherapy, 1, 377-389.
10. Menza, M., Vreeland, B., Minsky, S., Gara, M., Radler, D.R., & Sakowitz, M. (2004). Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. Journal of Clinical Psychiatry, 65, 471-477.
11. Minister of Public Works and Government Services Canada. (1997). Canada's food guide for healthy eating (Cat. No. H39-252/1992E). Ottowa, Ontario, Canada: Author.
12. Schieszer, J. (2004, March 9). Consensus statement tackles new antipsychotics. Medical Post, p. 76.
13. Virk, S., Schwartz, T.L., Jindal, S., Nihalani, N., & Jones, N. (2004). Psychiatric medication induced obesity: An aetiologic review. Obesity Reviews, 5, 167-170.
14. Wirshing, D.A., Boyd, J.A., Meng, L.R., Ballon, J.S., Marder, S.R., & Wirshing, W.C. (2002). The effects of novel antipsychotics on glucose and lipid levels. Journal of Clinical Psychiatry, 63, 856-865.
15. Yalom, I. (1983). Inpatient group psychotherapy. New York: Basic Books.
16. Zhu S., Wang, Z., Heshka, S., Heo, M., Faith, M.S., & Heymsfield, S.B. (2002). Waist circumference and obesity-associated factors among whites in the third National Health and Nutrition Examination Survey: Clinical action thresholds. American Journal of Clinical Nutrition, 76, 743-749.